UNIOSUN Staff Profile
Discover the People Behind Our Academic Excellence.
OMOLE Richard Kolade
Lecturer II
COLLEGE OF SCI. ENG. & TECH.
Microbiology
Brief Educational Profile
Dr Richard Kolade Omole is a Lecturer II in the Department of Microbiology at Osun State University, Osogbo, Nigeria, and a pioneering researcher at the forefront of the fight against Antimicrobial Resistance (AMR). His work bridges the critical intersection of microbiology, nanotechnology and public health to develop next-generation solutions for pressing global challenges.
Dr Omole is an alumnus of the prestigious Obafemi Awolowo University, Ile-Ife, Nigeria, where he earned B.Sc., M.Sc. and PhD degrees in Microbiology, spanning about 15 years.
An Innovation Fellow, Excellence in Entrepreneurship Development Awardee and top finalist in the Inaugural WIPO Nigeria Intellectual Property Incubation Lab, Dr Omole is a dedicated innovator. His research has yielded two Nigerian patents for biosynthesised nanomaterials, offering novel, sustainable, and semi-synthetic chemotherapeutic agents to combat multidrug-resistant wound infections, and for the detection of post-harvest deterioration. His expertise is recognised globally, with research awards from reputable organisations.
Dr Omole’s work, published in leading international journals, demonstrates a commitment to translating scientific discovery into tangible impact. His vision is to lead impactful, funded research that develops innovative biomedical tools, ensuring a safer and healthier future.
Academic Profiles
Selected Recent Publications
- - Omole, R. K., Torimiro, N., Adeyemi, O. I., Saravanan, M., and Ganesh, M. K. (2025). Bionanoformulated creams of silver (AgNPs), gold (AuNPs) and bimetallic silver-gold composites (Ag-AuNCPs) for tissue regeneration of MDR Pseudomonas aeruginosa-infected excision wounds in Wistar Rats. Colloids and Surfaces B: Biointerfaces, 256, 115067. https://doi.org/10.1016/j.colsurfb.2025.115067
- - Omole, R. K., Torimiro, N., Adeyemi, O. I., Saravanan, M., Agboluaje, E. O., Xiong, M. P., and George, R. C. (2025). Enhanced antibacterial efficacy of Lysinibacillus fusiformis-mediated bimetallic silver-gold nanocomposites against multidrug-resistant chronic wound bacterial pathogens. The Microbe, 6, 100275. https://doi.org/10.1016/j.microb.2025.100275
- - Omole, R. K., Agboluaje, E. O., Torimiro, N., Xiong, M. P., Adeyemi, O. I., George, R. C., Daramola, O. B., and Muthupandian, S. (2025). Intracellular Production of Gold Nanoparticles from Lysinibacillus fusiformis, Their Spectro-Structural Characterization and Antibacterial Potential on MDR Bacteria of Chronic Wounds. BioNanoScience, 15(2), 286. https://doi.org/10.1007/s12668-025-01904-8
- - Fasina, R. P., Omole, R. K., Titilawo, M. A., and Olaitan, J. O. (2025). Gas chromatography-mass spectrometry characterization of carotenoids produced by yeasts isolated from edible fruits and vegetables marketed in Osogbo metropolis, Southwest Nigeria. Discover Sustainability, 6(1), 333. https://doi.org/10.1007/s43621-025-01188-8
- - Daramola, O. B., Torimiro, N., Omole, R. K., Okugbesan, T. O., Olubamise, O. J., Akinsola, I. T., and Akinfolarin, O. O. (2025). Potential health and safety risk of enterotoxin-producing Bacillus species isolated from fermentation effluents discharged into the environment. Discover Toxicology, 2(1), 3. https://doi.org/10.1007/s44339-025-00020-2
- - Omole, R. K., George, R. C., Adeyemi, O. I., Torimiro, N., Saravanan, M., Agboluaje, E. O. and Xiong, M. P. (2024). Spectral Characterization of Silver Nanoparticles Biosynthesized from Lysinibacillus fusiformis and its Antibacterial Efficacy against Multidrug-Resistant Bacteria Isolated from Chronic Wounds. BioNanoScience, 14(2): 688-698. https://doi.org/10.1007/s12668-024-01382-4
- - Omole, R. K., Oluwatola, O., Akere, M. T., Eniafe, J., Agboluaje, E. O., Daramola, O. B., Ayantunji, Y. J., Omotade, T. I., Torimiro, N., Ayilara, M. S., Adeyemi, O. I. and Salinsile, O. S. (2022). Comprehensive assessment on the applications of oncolytic viruses in cancer immunotherapy. Frontiers in Pharmacology, 13(1082797): 1-29.
Research Interests
Applied Microbiology, Nanobiotechnology, Nanomedicine, Public Health Microbiology